Melanie Adler

592 total citations
9 papers, 397 citations indexed

About

Melanie Adler is a scholar working on Molecular Biology, Nephrology and Pharmacology. According to data from OpenAlex, Melanie Adler has authored 9 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Nephrology and 2 papers in Pharmacology. Recurrent topics in Melanie Adler's work include Heme Oxygenase-1 and Carbon Monoxide (2 papers), Cannabis and Cannabinoid Research (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). Melanie Adler is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (2 papers), Cannabis and Cannabinoid Research (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). Melanie Adler collaborates with scholars based in United States, Germany and Ireland. Melanie Adler's co-authors include Vishal S. Vaidya, Angela Mally, W. Dekant, Eva Rached, Dana Hoffmann, Joseph V. Bonventre, John J. Callanan, Susanne Ramm, Matthew Clement and Alexander Amberg and has published in prestigious journals such as Journal of the American Society of Nephrology, Carcinogenesis and Toxicological Sciences.

In The Last Decade

Melanie Adler

8 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melanie Adler United States 7 165 87 74 41 37 9 397
Mohammed Hasan Mukhtar Saudi Arabia 14 240 1.5× 39 0.4× 17 0.2× 20 0.5× 33 0.9× 33 535
Yoshito Ikeda Japan 15 199 1.2× 37 0.4× 18 0.2× 26 0.6× 19 0.5× 33 503
Nur Özten Kandaş Türkiye 13 130 0.8× 19 0.2× 12 0.2× 7 0.2× 26 0.7× 26 444
M N Yum United States 8 154 0.9× 41 0.5× 12 0.2× 50 1.2× 12 0.3× 11 422
Simone K. Frey Germany 11 316 1.9× 22 0.3× 16 0.2× 5 0.1× 20 0.5× 12 539
Yi Chi China 10 261 1.6× 8 0.1× 19 0.3× 38 0.9× 17 0.5× 12 436
Shourong Liu China 14 148 0.9× 28 0.3× 14 0.2× 40 1.0× 16 0.4× 52 457
Anna Zasowska‐Nowak Poland 7 118 0.7× 9 0.1× 29 0.4× 11 0.3× 21 0.6× 21 423
Xiaoliu Liang China 14 170 1.0× 5 0.1× 60 0.8× 49 1.2× 25 0.7× 19 460

Countries citing papers authored by Melanie Adler

Since Specialization
Citations

This map shows the geographic impact of Melanie Adler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Adler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Adler more than expected).

Fields of papers citing papers by Melanie Adler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Adler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Adler. The network helps show where Melanie Adler may publish in the future.

Co-authorship network of co-authors of Melanie Adler

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Adler. A scholar is included among the top collaborators of Melanie Adler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Adler. Melanie Adler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mahiny, Azita J., Kevin McClintock, Gábor Boros, et al.. (2023). ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model. Biomedicines. 11(6). 1735–1735. 6 indexed citations
2.
Ramm, Susanne, Melanie Adler, & Vishal S. Vaidya. (2016). A High‐Throughput Screening Assay to Identify Kidney Toxic Compounds. Current Protocols in Toxicology. 69(1). 9.10.1–9.10.26. 14 indexed citations
3.
Adler, Melanie, Susanne Ramm, Marc Hafner, et al.. (2015). A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro. Journal of the American Society of Nephrology. 27(4). 1015–1028. 95 indexed citations
4.
Quante, Mirja, Nadine D. Wolf, Elena Sergeyev, et al.. (2014). Managing incidental findings and disclosure of results in a paediatric research cohort – the LIFE Child Study cohort. Journal of Pediatric Endocrinology and Metabolism. 28(1-2). 75–82. 4 indexed citations
5.
Hoffmann, Dana, Melanie Adler, Vishal S. Vaidya, et al.. (2010). Performance of Novel Kidney Biomarkers in Preclinical Toxicity Studies. Toxicological Sciences. 116(1). 8–22. 85 indexed citations
6.
Adler, Melanie, et al.. (2009). Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity. Carcinogenesis. 30(4). 711–719. 56 indexed citations
7.
Hoffmann, Dana, Melanie Adler, Vishal S. Vaidya, et al.. (2009). Comparative Analysis of Novel Noninvasive Renal Biomarkers and Metabonomic Changes in a Rat Model of Gentamicin Nephrotoxicity. Toxicological Sciences. 109(2). 336–349. 108 indexed citations
8.
Adler, Melanie, Dana Hoffmann, Katja Matheis, et al.. (2009). Assessment of candidate biomarkers of drug induced liver injury in preclinical toxicity studies. Toxicology Letters. 189. S152–S152.
9.
O’Donnell, Lydia, Melanie Adler, Alexi San Doval, et al.. (2000). The role of technical assistance in the replication of effective HIV interventions.. PubMed. 12(5 Suppl). 99–111. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026